Perbedaan Kentanix Supra International Tbk. dan UBC Medical Indonesia Tbk.: Kentanix Supra International Tbk. diperdagangkan di Rp280 (kapitalisasi pasar 594,32 M, volume 24 jam 17 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt). Perbedaan utamanya: Kentanix Supra International Tbk. dan UBC Medical Indonesia Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 17 rb). Mana yang lebih baik tergantung tujuan investasimu.
| KSIX | LABS | |
|---|---|---|
Kapitalisasi Pasar | 594,32 M | 576,7 M |
Volume | 17 rb | 3,48 jt |
Lot | 170 | 34,82 rb |
Perputaran | 4,73 jt | 522,79 jt |
Harga Rata-rata | 278,14 | 150,13 |
Nilai Transaksi | 4,73 jt | 522,79 jt |
Harga Ekuilibrium Indikatif | 278 | 148 |
Volume Ekuilibrium Indikatif | 500 | 350 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Selengkapnya di halaman KSIX →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →